CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Option exercise Chief Scientific Officer acquired 1,050 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 3,875 shares (option exercise)
- 4 Option exercise President and CEO acquired 10,800 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- 4 Option exercise Chief Legal Officer acquired 45,518 shares (option exercise)
- 8-K Event Regulation FD disclosure
- 4 Gift Director gave 5,500 shares (gift)
- 4 Gift Chief Legal Officer gave 7,500 shares (gift)
- 4 Other disposition 10% owner disposed of 1,954,904 shares (other)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,041 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Agreement ended
- 4 Open-market sale Chief Medical Officer sold 2,631 shares at $16.98 ($44,675)
Page 18 of 44 · 872 filings